Gemcitabine

nucleosides category antineoplastic medicine.Applicable to nSCO, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

Now FDA has already commended this medicine for terminal and metastatic pancreatic cancer. Gemcitabine hydrochloride is a cytarabine analogue,belong to cell-cycle specificities antimetabolitas, acts on the tumor cell of DNA synthesis phase.Advantage:Wide range anticancer,special mechanism of action,low toxic effect,Non Cross Resistance in combination with other chemotherapeutics medicines,and non toxic effect superposition.